These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20183853)

  • 1. Understanding kinase selectivity through energetic analysis of binding site waters.
    Robinson DD; Sherman W; Farid R
    ChemMedChem; 2010 Apr; 5(4):618-27. PubMed ID: 20183853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective on computational and structural aspects of kinase discovery from IPK2014.
    Martin E; Knapp S; Engh RA; Moebitz H; Varin T; Roux B; Meiler J; Berdini V; Baumann A; Vieth M
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1595-604. PubMed ID: 25861861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing of new multi-targeted inhibitors of spleen tyrosine kinase (Syk) and zeta-associated protein of 70kDa (ZAP-70) using hierarchical virtual screening protocol.
    Kaur M; Kumari A; Bahia MS; Silakari O
    J Mol Graph Model; 2013 Feb; 39():165-75. PubMed ID: 23280414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies.
    Gambacorti-Passerini C; Gasser M; Ahmed S; Assouline S; Scapozza L
    Leukemia; 2005 Jul; 19(7):1267-9. PubMed ID: 15858616
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of type-II inhibitors using kinase structures.
    Lovering F; McDonald J; Whitlock GA; Glossop PA; Phillips C; Bent A; Sabnis Y; Ryan M; Fitz L; Lee J; Chang JS; Han S; Kurumbail R; Thorarensen A
    Chem Biol Drug Des; 2012 Nov; 80(5):657-64. PubMed ID: 22759374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anchor-based classification and type-C inhibitors for tyrosine kinases.
    Hsu KC; Sung TY; Lin CT; Chiu YY; Hsu JT; Hung HC; Sun CM; Barve I; Chen WL; Huang WC; Huang CT; Chen CH; Yang JM
    Sci Rep; 2015 Jun; 5():10938. PubMed ID: 26077136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Src, Syk, and Tec family kinases: distinct types of molecular switches.
    Bradshaw JM
    Cell Signal; 2010 Aug; 22(8):1175-84. PubMed ID: 20206686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
    Verkhivker GM
    Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine kinases: autoregulation and small-molecule inhibition.
    Hubbard SR
    Curr Opin Struct Biol; 2002 Dec; 12(6):735-41. PubMed ID: 12504677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly potent aminopyridines as Syk kinase inhibitors.
    Castillo M; Forns P; Erra M; Mir M; López M; Maldonado M; Orellana A; Carreño C; Ramis I; Miralpeix M; Vidal B
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5419-23. PubMed ID: 22877633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallography for protein kinase drug design: PKA and SRC case studies.
    Breitenlechner CB; Bossemeyer D; Engh RA
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):38-49. PubMed ID: 16269279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally.
    Mazuc E; Villoutreix BO; Malbec O; Roumier T; Fleury S; Leonetti JP; Dombrowicz D; Daëron M; Martineau P; Dariavach P
    J Allergy Clin Immunol; 2008 Jul; 122(1):188-94, 194.e1-3. PubMed ID: 18539317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors.
    Huang X; Cheng CC; Fischmann TO; Duca JS; Richards M; Tadikonda PK; Reddy PA; Zhao L; Siddiqui MA; Parry D; Davis N; Seghezzi W; Wiswell D; Shipps GW
    Bioorg Med Chem Lett; 2013 May; 23(9):2590-4. PubMed ID: 23535330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic prospect of Syk inhibitors.
    Ruzza P; Biondi B; Calderan A
    Expert Opin Ther Pat; 2009 Oct; 19(10):1361-76. PubMed ID: 19670961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches.
    Gani OA; Thakkar B; Narayanan D; Alam KA; Kyomuhendo P; Rothweiler U; Tello-Franco V; Engh RA
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1605-16. PubMed ID: 26001898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational study of Gleevec and G6G reveals molecular determinants of kinase inhibitor selectivity.
    Lin YL; Meng Y; Huang L; Roux B
    J Am Chem Soc; 2014 Oct; 136(42):14753-62. PubMed ID: 25243930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship studies of imidazo[1,2-c]pyrimidine derivatives as potent and orally effective Syk family kinases inhibitors.
    Hirabayashi A; Mukaiyama H; Kobayashi H; Shiohara H; Nakayama S; Ozawa M; Tsuji E; Miyazawa K; Misawa K; Ohnota H; Isaji M
    Bioorg Med Chem; 2008 Oct; 16(20):9247-60. PubMed ID: 18823784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the role of water molecules for docking and receptor guided 3D-QSAR analysis of naphthyridine derivatives as spleen tyrosine kinase (Syk) inhibitors.
    Kaur M; Bahia MS; Silakari O
    J Chem Inf Model; 2012 Oct; 52(10):2619-30. PubMed ID: 22900966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1.
    Zhang Z; Ojo KK; Johnson SM; Larson ET; He P; Geiger JA; Castellanos-Gonzalez A; White AC; Parsons M; Merritt EA; Maly DJ; Verlinde CL; Van Voorhis WC; Fan E
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5264-7. PubMed ID: 22795629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors.
    Xie HZ; Li LL; Ren JX; Zou J; Yang L; Wei YQ; Yang SY
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1944-9. PubMed ID: 19254842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.